Published in Mol Cell Biol on August 01, 1992
Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins. Mol Cell Biol (1994) 2.00
A heterodimer of HEB and an E12-related protein interacts with the CD4 enhancer and regulates its activity in T-cell lines. Mol Cell Biol (1993) 1.89
Mutations in TCF12, encoding a basic helix-loop-helix partner of TWIST1, are a frequent cause of coronal craniosynostosis. Nat Genet (2013) 1.82
The HAND1 basic helix-loop-helix transcription factor regulates trophoblast differentiation via multiple mechanisms. Mol Cell Biol (2000) 1.80
A novel snail-related transcription factor Smuc regulates basic helix-loop-helix transcription factor activities via specific E-box motifs. Nucleic Acids Res (2000) 1.37
E2A basic-helix-loop-helix transcription factors are negatively regulated by serum growth factors and by the Id3 protein. Nucleic Acids Res (1996) 1.21
Second-site proviral enhancer alterations in lymphomas induced by enhancer mutants of SL3-3 murine leukemia virus: negative effect of nuclear factor 1 binding site. J Virol (1997) 1.07
Determination of recognition-sequences for DNA-binding proteins by a polymerase chain reaction assisted binding site selection method (BSS) using nitrocellulose immobilized DNA binding protein. Nucleic Acids Res (1992) 0.91
Lack of shielding of primer binding site silencer-mediated repression of an internal promoter in a retrovirus vector by the putative insulators scs, BEAD-1, and HS4. J Virol (2000) 0.90
Helix-loop-helix transcription factors mediate activation and repression of the p75LNGFR gene. Mol Cell Biol (1995) 0.90
Basic helix-loop-helix proteins in murine type C retrovirus transcriptional regulation. J Virol (1994) 0.89
Origins of enhancer sequences of recombinant murine leukemia viruses from spontaneous B- and T-cell lymphomas of CWD mice. J Virol (1994) 0.88
Various modes of basic helix-loop-helix protein-mediated regulation of murine leukemia virus transcription in lymphoid cell lines. J Virol (1996) 0.88
HEB in the spotlight: Transcriptional regulation of T-cell specification, commitment, and developmental plasticity. Clin Dev Immunol (2012) 0.86
Pan/E2A expression precedes immunoglobulin heavy-chain expression during B lymphopoiesis in nontransformed cells, and Pan/E2A proteins are not detected in myeloid cells. Mol Cell Biol (1994) 0.86
Members of the GATA family of transcription factors bind to the U3 region of Cas-Br-E and graffi retroviruses and transactivate their expression. J Virol (1998) 0.80
Suppression of chondrogenesis by Id helix-loop-helix proteins in murine embryonic orofacial tissue. Differentiation (2009) 0.78
Interplay of the E box, the cyclic AMP response element, and HTF4/HEB in transcriptional regulation of the neurospecific, neurotrophin-inducible vgf gene. Mol Cell Biol (1997) 0.77
A novel initiator regulates expression of the nontissue-specific helix-loop-helix gene ME1. Nucleic Acids Res (1995) 0.76
A murine leukemia virus with Cre-LoxP excisible coding sequences allowing superinfection, transgene delivery, and generation of host genomic deletions. Retrovirology (2004) 0.75
Expression of a quail bHLH transcription factor is associated with adrenergic development in trunk neural crest cultures. Cell Mol Neurobiol (1997) 0.75
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry (1979) 180.95
Studies on transformation of Escherichia coli with plasmids. J Mol Biol (1983) 116.81
Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol (1990) 61.47
Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol (1986) 55.34
The scanning model for translation: an update. J Cell Biol (1989) 31.23
The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science (1988) 27.01
Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell (1987) 22.17
A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell (1989) 21.54
A short amino acid sequence able to specify nuclear location. Cell (1984) 21.17
Yeast RNA polymerase II genes: isolation with antibody probes. Science (1983) 17.91
Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science (1986) 15.84
The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell (1990) 15.36
Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell (1989) 14.24
Host specificity of DNA produced by Escherichia coli: bacterial mutations affecting the restriction and modification of DNA. J Mol Biol (1966) 12.77
The rapid generation of oligonucleotide-directed mutations at high frequency using phosphorothioate-modified DNA. Nucleic Acids Res (1985) 12.11
B lineage--specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science (1985) 9.73
Transcription activation by the adenovirus E1a protein. Nature (1989) 9.08
Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells. J Mol Appl Genet (1983) 8.94
Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell (1986) 8.87
The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain. Cell (1989) 8.60
Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell (1989) 8.42
Molecular cloning of an enhancer binding protein: isolation by screening of an expression library with a recognition site DNA. Cell (1988) 8.00
Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature (1988) 7.99
Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility. Science (1987) 7.63
In situ detection of sequence-specific DNA binding activity specified by a recombinant bacteriophage. Genes Dev (1988) 6.97
A family of human CCAAT-box-binding proteins active in transcription and DNA replication: cloning and expression of multiple cDNAs. Nature (1988) 6.54
A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. EMBO J (1989) 6.37
TFE3: a helix-loop-helix protein that activates transcription through the immunoglobulin enhancer muE3 motif. Genes Dev (1990) 6.00
Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins. Nature (1986) 5.90
Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif. Science (1990) 4.93
An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers. Cell (1991) 4.80
Molecular cloning of infectious integrated murine leukemia virus DNA from infected mouse cells. Proc Natl Acad Sci U S A (1980) 4.71
Identification of MRF4: a new member of the muscle regulatory factor gene family. Genes Dev (1989) 4.50
The achaete-scute gene complex of D. melanogaster: conserved domains in a subset of genes required for neurogenesis and their homology to myc. Cell (1987) 4.43
Tissue-specific transcription preference as a determinant of cell tropism and leukaemogenic potential of murine retroviruses. Nature (1984) 4.30
Mutations that disrupt DNA binding and dimer formation in the E47 helix-loop-helix protein map to distinct domains. Proc Natl Acad Sci U S A (1990) 4.03
Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer. Mol Cell Biol (1987) 4.02
Cell-type-specific contacts to immunoglobulin enhancers in nuclei. Nature (1985) 3.94
extramacrochaetae, a negative regulator of sensory organ development in Drosophila, defines a new class of helix-loop-helix proteins. Cell (1990) 3.15
A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity. Cell (1991) 3.12
The Drosophila extramacrochaetae locus, an antagonist of proneural genes that, like these genes, encodes a helix-loop-helix protein. Cell (1990) 3.08
First-strand cDNA synthesis primed with oligo(dT). Methods Enzymol (1987) 3.06
The achaete-scute gene complex of Drosophila melanogaster comprises four homologous genes. EMBO J (1988) 3.00
Biochemical analysis of transcriptional activation by Jun: differential activity of c- and v-Jun. Cell (1989) 2.93
HEB, a helix-loop-helix protein related to E2A and ITF2 that can modulate the DNA-binding ability of myogenic regulatory factors. Mol Cell Biol (1992) 2.72
Pan: a transcriptional regulator that binds chymotrypsin, insulin, and AP-4 enhancer motifs. Genes Dev (1990) 2.46
An Id-related helix-loop-helix protein encoded by a growth factor-inducible gene. Proc Natl Acad Sci U S A (1991) 2.44
Translational activation of the lck proto-oncogene. Nature (1988) 2.41
Characterization of a bipartite activator domain in transcription factor CREB. Cell (1990) 2.41
Two adjacent MyoD1-binding sites regulate expression of the acetylcholine receptor alpha-subunit gene. Nature (1990) 2.39
Alignment of U3 region sequences of mammalian type C viruses: identification of highly conserved motifs and implications for enhancer design. J Virol (1990) 2.34
B-cell- and myocyte-specific E2-box-binding factors contain E12/E47-like subunits. Mol Cell Biol (1991) 2.28
Molecular characterization of daughterless, a Drosophila sex determination gene with multiple roles in development. Genes Dev (1988) 2.13
Muscle-specific expression of the troponin I gene requires interactions between helix-loop-helix muscle regulatory factors and ubiquitous transcription factors. Mol Cell Biol (1991) 2.05
Transcriptional activation by heterodimers of the achaete-scute and daughterless gene products of Drosophila. EMBO J (1991) 2.04
Second-strand cDNA synthesis: mRNA fragments as primers. Methods Enzymol (1987) 1.88
Two different factors act separately or together to specify functionally distinct activities at a single transcriptional enhancer. Mol Cell Biol (1986) 1.86
Functional characterization of the developmentally controlled immunoglobulin kappa 3' enhancer: regulation by Id, a repressor of helix-loop-helix transcription factors. Mol Cell Biol (1991) 1.74
Point mutations in the Moloney murine leukemia virus enhancer identify a lymphoid-specific viral core motif and 1,3-phorbol myristate acetate-inducible element. J Virol (1990) 1.74
A cDNA from a mouse pancreatic beta cell encoding a putative transcription factor of the insulin gene. Nucleic Acids Res (1990) 1.49
HTF4: a new human helix-loop-helix protein. Nucleic Acids Res (1991) 1.43
Sequencing and expression of complementary DNA for the general transcription factor BTF3. Nature (1990) 1.38
Regulatory elements within the murine leukemia virus enhancer regions mediate glucocorticoid responsiveness. J Virol (1988) 1.21
The role of MuLV receptors on T-lymphoma cells in lymphoma cell proliferation. Contemp Top Immunobiol (1980) 1.19
DNA-binding motif. Nature (1989) 1.16
Glucocorticoid regulation of murine leukemia virus transcription elements is specified by determinants within the viral enhancer region. J Virol (1987) 1.09
Enhancer functions in U3 of Akv virus: a role for cooperativity of a tandem repeat unit and its flanking DNA sequences. J Virol (1990) 1.04
Different mechanisms regulate muscle-specific AChR gamma- and epsilon-subunit gene expression. EMBO J (1991) 0.99
Purification of large double-stranded cDNA fragments. Methods Enzymol (1987) 0.85
Cloning and sequence analysis of TFE, a helix-loop-helix transcription factor able to recognize the thyroglobulin gene promoter in vitro. Nucleic Acids Res (1991) 0.85
The prognostic value of serum troponin T in unstable angina. N Engl J Med (1992) 5.04
The primary structures of two leghemoglobin genes from soybean. Nucleic Acids Res (1982) 2.64
A micromethod for detailed characterization of high molecular weight RNA. Methods Enzymol (1980) 2.36
Amplification and sequence analysis of DNA flanking integrated proviruses by a simple two-step polymerase chain reaction method. J Virol (1993) 2.22
Genomic changes associated with antigenic variation of visna virus durig persistent infection. Proc Natl Acad Sci U S A (1980) 2.04
Novel leukaemogenic retroviruses isolated from cell line derived from spontaneous AKR tumour. Nature (1981) 1.97
SL3-3 enhancer factor 1 transcriptional activators are required for tumor formation by SL3-3 murine leukemia virus. J Virol (1991) 1.92
Biochemical evidence that "new" influenza virus strains in nature may arise by recombination (reassortment). Proc Natl Acad Sci U S A (1978) 1.86
A nucleotide substitution in the gag N terminus of the endogenous ecotropic DBA/2 virus prevents Pr65gag myristylation and virus replication. J Virol (1988) 1.72
Analysis of the genome of an endogenous, ecotropic retrovirus of the AKR strain of mice: micromethod for detailed characterization of high-molecular-weight RNA. J Virol (1980) 1.69
Chimeras of receptors for gibbon ape leukemia virus/feline leukemia virus B and amphotropic murine leukemia virus reveal different modes of receptor recognition by retrovirus. J Virol (1995) 1.59
The nucleotide sequence of the Akv murine leukemia virus genome. Virology (1984) 1.51
Mutated primer binding sites interacting with different tRNAs allow efficient murine leukemia virus replication. J Virol (1993) 1.50
Poorly expressed endogenous ecotropic provirus of DBA/2 mice encodes a mutant Pr65gag protein that is not myristylated. J Virol (1988) 1.43
Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood (1998) 1.42
Origin of replication, oriC, of the Escherichia coli chromosome: mapping of genes relative to R.EcoRI cleavage sites in the oriC region. Mol Gen Genet (1977) 1.42
The importance of KRAS mutations and EGF61A>G polymorphism to the effect of cetuximab and irinotecan in metastatic colorectal cancer. Ann Oncol (2009) 1.40
Matrix protein of Akv murine leukemia virus: genetic mapping of regions essential for particle formation. J Virol (1992) 1.37
Most sequence differences between the genomes of the Akv virus and a leukemogenic Gross A virus passaged in vitro are located near the 3' terminus. Proc Natl Acad Sci U S A (1980) 1.36
OPUS study: suicidal behaviour, suicidal ideation and hopelessness among patients with first-episode psychosis. One-year follow-up of a randomised controlled trial. Br J Psychiatry Suppl (2002) 1.35
A ribosomal RNA gene, rrnC, of Escherichia coli, mapped by specialized transducing lambdadilv and lambda drbs phages. Mol Gen Genet (1978) 1.31
Oncogenic retrovirus from spontaneous murine osteomas. I. Isolation and biological characterization. J Gen Virol (1984) 1.29
Different relative expression from two murine leukemia virus long terminal repeats in unintegrated transfected DNA and in integrated retroviral vector proviruses. J Virol (1989) 1.25
Analysis of the relA gene product of Escherichia coli. Eur J Biochem (1977) 1.22
Graduated resistance to G418 leads to differential selection of cultured mammalian cells expressing the neo gene. Gene (1989) 1.18
Anaerobic power and muscle strength characteristics of 11 years old elite and non-elite boys and girls from gymnastics, team handball, tennis and swimming. Scand J Med Sci Sports (2002) 1.17
Characterization of virus produced by a lymphoma induced by inoculation of AKR MCF-247 virus. J Virol (1980) 1.16
Increased cloning efficiency by temperature-cycle ligation. Nucleic Acids Res (1996) 1.14
Integrated treatment ameliorates negative symptoms in first episode psychosis--results from the Danish OPUS trial. Schizophr Res (2005) 1.14
Sequence tags of provirus integration sites in DNAs of tumors induced by the murine retrovirus SL3-3. J Virol (1996) 1.12
Structure of retroviral RNAs produced by cell lines derived from spontaneous lymphomas of AKR mice. J Virol (1982) 1.12
A preferred region for recombinational patch repair in the 5' untranslated region of primer binding site-impaired murine leukemia virus vectors. J Virol (1996) 1.10
Oncogenic retrovirus from spontaneous murine osteomas. II. Molecular cloning and genomic characterization. Virology (1986) 1.09
Second-site proviral enhancer alterations in lymphomas induced by enhancer mutants of SL3-3 murine leukemia virus: negative effect of nuclear factor 1 binding site. J Virol (1997) 1.07
Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo. J Virol (1997) 1.06
Isolation of a lambda transducing bacteriophage carrying the relA gene of Escherichia coli. J Bacteriol (1976) 1.05
RNA levels of human retrovirus receptors Pit1 and Pit2 do not correlate with infectibility by three retroviral vector pseudotypes. Hum Gene Ther (1998) 1.04
CPP1, a DNA-binding protein involved in the expression of a soybean leghemoglobin c3 gene. Proc Natl Acad Sci U S A (2000) 1.04
B-Cell lymphoma induction by akv murine leukemia viruses harboring one or both copies of the tandem repeat in the U3 enhancer. J Virol (1998) 1.04
Enhancer functions in U3 of Akv virus: a role for cooperativity of a tandem repeat unit and its flanking DNA sequences. J Virol (1990) 1.04
Sint1, a common integration site in SL3-3-induced T-cell lymphomas, harbors a putative proto-oncogene with homology to the septin gene family. J Virol (2000) 1.03
Tumor model-specific proviral insertional mutagenesis of the Fos/Jdp2/Batf locus. Virology (2005) 1.03
Complementation of a primer binding site-impaired murine leukemia virus-derived retroviral vector by a genetically engineered tRNA-like primer. J Virol (1997) 1.03
Recombination in the 5' leader of murine leukemia virus is accurate and influenced by sequence identity with a strong bias toward the kissing-loop dimerization region. J Virol (1998) 1.01
Genetic reassortment and patch repair by recombination in retroviruses. J Biomed Sci (2000) 1.00
Quantitative determination of IL-1 alpha-induced IL-8 mRNA levels in cultured human keratinocytes, dermal fibroblasts, endothelial cells, and monocytes. J Invest Dermatol (1991) 0.99
Multiple sequence elements in the U3 region of the leukemogenic murine retrovirus SL3-2 contribute to cell-dependent gene expression. Virology (1990) 0.97
Efficient non-PCR-mediated overlap extension of PCR fragments by exonuclease "end polishing". Biotechniques (1997) 0.97
Mutations of the kissing-loop dimerization sequence influence the site specificity of murine leukemia virus recombination in vivo. J Virol (2000) 0.96
The association between pre-morbid adjustment, duration of untreated psychosis and outcome in first-episode psychosis. Psychol Med (2008) 0.96
Comparative analysis of RNA tumor virus genomes. Haematol Blood Transfus (1979) 0.96
Alleviation of murine leukemia virus repression in embryonic carcinoma cells by genetically engineered primer binding sites and artificial tRNA primers. Virology (2000) 0.95
An SL3-3 murine leukemia virus enhancer variant more pathogenic than the wild type obtained by assisted molecular evolution in vivo. J Virol (1997) 0.95
KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer. Br J Cancer (2013) 0.94
Single amino acid insertion in loop 4 confers amphotropic murine leukemia virus receptor function upon murine Pit1. J Virol (1998) 0.94
Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants. J Virol (1997) 0.94
Quantitative assessment of the JAK2 V617F allele burden: equivalent levels in peripheral blood and bone marrow. Leukemia (2007) 0.93
A new class of plant homeobox genes is expressed in specific regions of determinate symbiotic root nodules. Plant Mol Biol (1999) 0.92
E-box sequence and context-dependent TAL1/SCL modulation of basic helix-loop-helix protein-mediated transcriptional activation. J Biol Chem (1996) 0.92
Amphotropic murine leukemia virus entry is determined by specific combinations of residues from receptor loops 2 and 4. J Virol (1999) 0.92
Expression of type III sodium-dependent phosphate transporters/retroviral receptors mRNAs during osteoblast differentiation. Bone (2001) 0.92
Determination of recognition-sequences for DNA-binding proteins by a polymerase chain reaction assisted binding site selection method (BSS) using nitrocellulose immobilized DNA binding protein. Nucleic Acids Res (1992) 0.91
Lack of shielding of primer binding site silencer-mediated repression of an internal promoter in a retrovirus vector by the putative insulators scs, BEAD-1, and HS4. J Virol (2000) 0.90
Basic helix-loop-helix proteins in murine type C retrovirus transcriptional regulation. J Virol (1994) 0.89
Expression of heterologous genes from an IRES translational cassette in replication competent murine leukemia virus vectors. Gene (1999) 0.89
The kissing-loop motif is a preferred site of 5' leader recombination during replication of SL3-3 murine leukemia viruses in mice. J Virol (1999) 0.89
Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia. Br J Cancer (2002) 0.89
Interaction between the transcription factor SPBP and the positive cofactor RNF4. An interplay between protein binding zinc fingers. J Biol Chem (2000) 0.89
Mammalian expression-and-transmission vector derived from Akv murine leukemia virus. Gene (1986) 0.89
Lack of correlation between basal expression levels and susceptibility to transcriptional shutdown among single-gene murine leukemia virus vector proviruses. J Virol (1994) 0.88
Kinetics of BCR-ABL fusion transcript levels in chronic myeloid leukemia patients treated with STI571 measured by quantitative real-time polymerase chain reaction. Eur J Haematol (2002) 0.88
Various modes of basic helix-loop-helix protein-mediated regulation of murine leukemia virus transcription in lymphoid cell lines. J Virol (1996) 0.88
In vivo gene delivery to articular chondrocytes mediated by an adeno-associated virus vector. J Orthop Res (2004) 0.87
Measurement of hygromycin B phosphotransferase activity in crude mammalian cell extracts by a simple dot-blot assay. Gene (1992) 0.87